首页> 外文期刊>Journal of public health management and practice: JPHMP >Response to the US FDA LeadCare Testing Systems Recall and CDC Health Alert
【24h】

Response to the US FDA LeadCare Testing Systems Recall and CDC Health Alert

机译:回复美国FDA Leadcare测试系统召回和CDC Health Alert

获取原文
获取原文并翻译 | 示例
           

摘要

On May 17, 2017, the Food and Drug Administration issued a safety recall for the Magellan Diagnostics' LeadCare Testing Systems due to the potential for inaccurately low blood lead test results when used with venous blood samples. Concurrently, the Centers for Disease Control and Prevention (CDC) issued a health alert with retesting recommendations for specific high-risk populations. The purpose of the CDC retesting recommendations was to help identify high-risk individuals so that those potentially impacted by falsely low test results could be retested and receive appropriate follow-up care. The CDC's Lead Poisoning Prevention Program sought to understand how the recall and recommendations impacted state and local public health agencies. Childhood lead poisoning prevention programs (CLPPPs) in state and local public health agencies collect blood lead test results for children and had a lead role in identifying children for retesting. Case studies are presented that highlight the experiences of 4 state CLPPPs in responding to the recall and recommendations. Collectively, the case studies point to several lessons learned, including the importance of (1) having a well-functioning surveillance system in place prior to a serious incident; (2) having a clear understanding of the roles partners play in the continuum of care for children potentially exposed to lead; and (3) ensuring effective communications with all staff, both internal and external, to public health agencies that have a role in responding to a serious incident. The ability to respond to public health emergencies or other serious incidents takes the combined effort of federal, state, and local public health agencies as well as others in the health care delivery system. The CDC will continue to support state and local lead poisoning prevention programs so that they have the information and tools they need to address and prevent the health effects of lead exposures in communities.
机译:2017年5月17日,由于与静脉血样使用时,食品和药物管理局为Magellan Diagnostics Leadcare测试系统发出了安全回忆。同时,疾病控制和预防的中心(CDC)发出了对特定高风险群体的重新建议的健康警报。 CDC重试建议的目的是帮助识别高风险的个体,以便可以重新测试和获得适当的后续护理,以识别高风险的个体。 CDC的铅中毒预防计划试图了解召回和建议如何影响国家和地方公共卫生机构。童年铅中毒预防计划(CLPPP)在国家和地方公共卫生机构中收集儿童的血铅测试结果,并在识别儿童进行重新测试方面发挥着主导作用。提出了案例研究,突出了4个国家CLPPP的经验回顾和建议。案例研究指出了几个经验教训,包括在严重事件之前在有效的监测系统中具有良好运作的监测系统的重要性; (2)清楚地了解伙伴合作伙伴在潜在暴露于铅的儿童的连续性中发挥作用; (3)确保与所有工作人员,内部和外部的所有工作人员进行有效沟通,该公共卫生机构在响应严重事件方面发挥作用。应对公共卫生紧急情况或其他严重事件的能力采取联邦,州和当地公共卫生机构以及卫生保健交付系统中的其他人的综合努力。 CDC将继续支持国家和地方铅中毒预防计划,以便他们拥有所需的信息和工具,他们需要解决并防止铅暴露在社区中的健康影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号